Metraipolis › archive › dc_883dfdad7862

Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer — Europe PMC PMID:40935852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40935852
DOI
10.1038/s12276-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-09T23:43:26.539Z
SHA-256 of the archived text
165066e651938a090e10229fb67c2b46d487de4928ab4ff25db7182e79807628
Stable URL of this page
https://metraipolis.com/documento/dc_883dfdad7862

How to cite

Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer — Europe PMC PMID:40935852 — Europe PMC (en), https://europepmc.org/article/MED/40935852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_883dfdad7862 (Metraipolis archive dc_883dfdad7862, sha256 165066e651938a090e10229fb67c2b46d487de4928ab4ff25db7182e79807628)
BibTeX
@misc{dc883dfdad7862,
  title = {Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer — Europe PMC PMID:40935852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40935852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_883dfdad7862; sha256 165066e651938a090e10229fb67c2b46d487de4928ab4ff25db7182e79807628},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40935852. Agents can read the archived copy with the MCP tool read_document.